These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drug prescription patterns for rheumatic disorders in Sweden. Bjelle A; Mjörndal T J Rheumatol; 1984 Aug; 11(4):493-9. PubMed ID: 6434737 [TBL] [Abstract][Full Text] [Related]
25. [Selective bone marrow damage caused by butazolidin and pyramidon in a child with subsepsis allergica]. SANSONE G; MASSIMO L Minerva Pediatr; 1958 Jun; 10(23-24):637-40. PubMed ID: 13565828 [No Abstract] [Full Text] [Related]
26. [Monophenylbutazone as a combined preparation in rheumatology]. Priessnitz O Hippokrates; 1968 Jul; 39(14):545-7. PubMed ID: 5306047 [No Abstract] [Full Text] [Related]
27. Therapeutic gold. Is it due for a come-back? Whitehouse MW Inflammopharmacology; 2008 Jun; 16(3):107-9. PubMed ID: 18521542 [TBL] [Abstract][Full Text] [Related]
29. The role of therapeutic plasmapheresis in the rheumatic diseases. Jones JV; Clough JD; Klinenberg JR; Davis P J Lab Clin Med; 1981 May; 97(5):589-98. PubMed ID: 6452484 [No Abstract] [Full Text] [Related]
30. New classification of antirheumatic drugs. The evolution of a concept. Edmonds JP; Scott DL; Furst DE; Paulus HE J Rheumatol; 1993 Mar; 20(3):585-7. PubMed ID: 8478880 [No Abstract] [Full Text] [Related]
31. Drug interaction between chlorpropamide and non-steroidal anti-inflammatory drugs, ibuprofen and phenylbutazone. Shah SJ; Bhandarkar SD; Satoskar RS Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):470-2. PubMed ID: 6500764 [TBL] [Abstract][Full Text] [Related]
32. The beneficial effect of gold salts and phenylbutazone (butazolidin) in chronic ulcerative colitis with arthritis. GRANIRER LW N Y State J Med; 1958 Nov; 58(21):3467-9. PubMed ID: 13590505 [No Abstract] [Full Text] [Related]
33. Clinical pharmacology of gold. Kean WF; Kean IR Inflammopharmacology; 2008 Jun; 16(3):112-25. PubMed ID: 18523733 [TBL] [Abstract][Full Text] [Related]
34. Rheumatic diseases in the elderly. Finding a way through the maze. Calkins E Prim Care; 1982 Mar; 9(1):181-95. PubMed ID: 6978496 [TBL] [Abstract][Full Text] [Related]
35. [What's new in rheumatology--trends in rheumatological pharmacotherapy (author's transl)]. Mennet P Schweiz Rundsch Med Prax; 1981 Oct; 70(42):1831-4. PubMed ID: 6975935 [No Abstract] [Full Text] [Related]
36. [Clinical experience with a rubidium-gold-creatinine-gold preparation in rheumatic diseases]. POHL W Medizinische; 1954 May; 18():659-61. PubMed ID: 13175984 [No Abstract] [Full Text] [Related]
37. [Phenylbutazone in rheumatic diseases]. FRANCE O; LOSADA M Rev Med Chil; 1957 Dec; 85(12):725-30. PubMed ID: 13528121 [No Abstract] [Full Text] [Related]
38. [Phenylbutazone in various rheumatic diseases]. COSSERMELLI W; GIANNINI SG; SPILBORGHS G Rev Assoc Med Bras; 1956 Sep; 2(4):341-4. PubMed ID: 13389893 [No Abstract] [Full Text] [Related]
39. [Results obtained with the use of phenylbutazone in patients with various rheumatic diseases]. GAMARSKI J Med Cir Farm; 1958 Dec; 20(272):575-83. PubMed ID: 13621959 [No Abstract] [Full Text] [Related]
40. [Experiences with phenylbutazone therapy in 130 cases of rheumatic diseases]. STOIA I; NITESCU S; GRUNWALD L; LEIBOVICI S Z Rheumaforsch; 1957 Jun; 16(5-6):146-50. PubMed ID: 13456918 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]